{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T04:55:58Z","timestamp":1789275358961,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004726","name":"Ministry of Health, British Columbia","doi-asserted-by":"publisher","award":["H08-02095"],"award-info":[{"award-number":["H08-02095"]}],"id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine Reports"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.pmedr.2023.102305","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T01:20:38Z","timestamp":1688001638000},"page":"102305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Characterizing opioid agonist therapy uptake and factors associated with treatment retention among people with HIV in British Columbia, Canada"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1929-729X","authenticated-orcid":false,"given":"Kiana","family":"Yazdani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Dolguikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Trigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Joe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio S.G.","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Salters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmedr.2023.102305_b0005","unstructured":"National Academies of Sciences E, Medicine, Health, Medicine D, Board on Health Sciences P, Committee on Medication-Assisted Treatment for Opioid Use D., 2019. The national academies collection: reports funded by national institutes of health. In: Mancher, M., Leshner, A.I. (Eds.), Medications for Opioid Use Disorder Save Lives. National Academies Press (US), Washington (DC)."},{"issue":"1","key":"10.1016\/j.pmedr.2023.102305_b0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biopsych.2019.06.020","article-title":"Medication treatment of opioid use disorder","volume":"87","author":"Bell","year":"2020","journal-title":"Biol. Psychiatr."},{"issue":"10182","key":"10.1016\/j.pmedr.2023.102305_b0015","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: present status and future directions","volume":"393","author":"Blanco","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pmedr.2023.102305_b0020","unstructured":"British Columbia Center for Excellence in HIV\/AIDS, 2020. Drug Treatment Program. http:\/\/bccfe.ca\/drug-treatment-program."},{"key":"10.1016\/j.pmedr.2023.102305_b0025","unstructured":"British Columbia Centre on Substance Use and British Columbia Ministry of Health, 2017. https:\/\/www.bccsu.ca\/wp-content\/uploads\/2018\/05\/BC_OUD_Guideline.pdf."},{"key":"10.1016\/j.pmedr.2023.102305_b0030","unstructured":"British Columbia Coroners Service, 2019. https:\/\/www2.gov.bc.ca\/assets\/gov\/overdose-awareness\/mmha_escalating_bcs_response_report_final_26feb.pdf."},{"key":"10.1016\/j.pmedr.2023.102305_b0035","unstructured":"British Columbia Ministry of Health, 2016. PharmaNet. V2. http:\/\/www.popdata.bc.ca\/data."},{"key":"10.1016\/j.pmedr.2023.102305_b0040","unstructured":"British Columbia Ministry of Health, 2016. Medical Services Plan (MSP) Payment Information File. V2. http:\/\/www.popdata.bc.ca\/data."},{"key":"10.1016\/j.pmedr.2023.102305_b0045","unstructured":"British Columbia Vital Statistics Agency, 2016. Vital Statistics Deaths. V2. http:\/\/www.popdata.bc.ca\/data."},{"key":"10.1016\/j.pmedr.2023.102305_b0050","unstructured":"Canadian Institute for Health Information, 2016. Discharge Abstract Database (Hospital Separations). V2. http:\/\/www.popdata.bc.ca\/data."},{"key":"10.1016\/j.pmedr.2023.102305_b0055","unstructured":"British Columbia Centre for Disease Control, 2020. http:\/\/www.bccdc.ca\/our-services\/service-areas\/bccdc-public-health-laboratory."},{"key":"10.1016\/j.pmedr.2023.102305_b0060","unstructured":"BC Centre for Substance Use Disorder, 2020. Supervised Injectable Opioid Agonist Treatment Guidance. https:\/\/www.bccsu.ca\/wp-content\/uploads\/2021\/07\/BC_iOAT_Guideline.pdf."},{"key":"10.1016\/j.pmedr.2023.102305_b0065","unstructured":"Chronic Disease Information Working Group, 2018. BC Chronic Disease and Selected Procedure Case Definitions. http:\/\/www.bccdc.ca\/health-professionals\/data-reports\/chronic-disease-dashboard#Case--Definitions."},{"key":"10.1016\/j.pmedr.2023.102305_b0070","doi-asserted-by":"crossref","first-page":"109494","DOI":"10.1016\/j.drugalcdep.2022.109494","article-title":"The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: a retrospective data linkage study","volume":"236","author":"Colledge-Frisby","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pmedr.2023.102305_b0075","unstructured":"The College of Physicians & Surgeons of Manitoba Opioid Agonist Therapy Recommended Practice Manual, 2022. Alternative Treatment Approaches to Opioid Use Disorder Including Slow-Release Oral Morphine (Kadian\u00ae). https:\/\/cpsm.mb.ca\/assets\/PrescribingPracticesProgram\/Alternative%20Guidance%20-%20Alternative%20Treatment%20Approaches%20for%20OUD%20Including%20SROM.pdf."},{"issue":"4","key":"10.1016\/j.pmedr.2023.102305_b0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/QAD.0b013e32834f19b6","article-title":"HIV infection and risk of overdose: a systematic review and meta-analysis","volume":"26","author":"Green","year":"2012","journal-title":"AIDS (London, England)"},{"issue":"4","key":"10.1016\/j.pmedr.2023.102305_b0085","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/ije\/dyu070","article-title":"Cohort profile: Seek and treat for the optimal prevention of HIV\/AIDS in British Columbia (STOP HIV\/AIDS BC)","volume":"43","author":"Heath","year":"2014","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.pmedr.2023.102305_b0090","doi-asserted-by":"crossref","first-page":"108799","DOI":"10.1016\/j.drugalcdep.2021.108799","article-title":"Characterizing opioid agonist treatment discontinuation trends in British Columbia, Canada, 2012\u20132018","volume":"225","author":"Krebs","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pmedr.2023.102305_b0095","doi-asserted-by":"crossref","first-page":"108647","DOI":"10.1016\/j.jsat.2021.108647","article-title":"Assessing the determinants of completing OAT induction and long-term retention: a population-based study in British Columbia, Canada","volume":"133","author":"Kurz","year":"2022","journal-title":"J. Substance Abuse Treat."},{"issue":"4","key":"10.1016\/j.pmedr.2023.102305_b0100","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/QAI.0b013e3181f2ac87","article-title":"Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level","volume":"55","author":"Lima","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"6","key":"10.1016\/j.pmedr.2023.102305_b0105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"issue":"3","key":"10.1016\/j.pmedr.2023.102305_b0110","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/QAI.0000000000001827","article-title":"Opioid agonist treatment and improved outcomes at each stage of the HIV treatment cascade in people who inject drugs in Ukraine","volume":"79","author":"Mazhnaya","year":"2018","journal-title":"J. Acquired Immune Deficiency Syndr."},{"key":"10.1016\/j.pmedr.2023.102305_b0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijid.2016.03.022","article-title":"Association of opioid agonist therapy with the initiation of antiretroviral therapy - a systematic review","volume":"46","author":"Mlunde","year":"2016","journal-title":"Int. J. Infect. Dis. IJID: Off. Publ. Int. Soc. Infect. Dis."},{"issue":"1","key":"10.1016\/j.pmedr.2023.102305_b0120","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-021-01448-x","article-title":"The impact of lookback windows on the prevalence and incidence of chronic diseases among people living with HIV: an exploration in administrative health data in Canada","volume":"22","author":"Nanditha","year":"2022","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"10.1016\/j.pmedr.2023.102305_b0125","doi-asserted-by":"crossref","first-page":"e54416","DOI":"10.1371\/journal.pone.0054416","article-title":"Application and validation of case-finding algorithms for identifying individuals with human immunodeficiency virus from administrative data in British Columbia, Canada","volume":"8","author":"Nosyk","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.pmedr.2023.102305_b0130","unstructured":"Officer, P.H., 2022. Stopping the harm: Decriminalization of People Who Use Drugs in BC. https:\/\/www2.gov.bc.ca\/assets\/gov\/health\/about-bc-s-health-care-system\/office-of-the-provincial-health-officer\/reports-publications\/special-reports\/stopping-the-harm-report.pdf."},{"key":"10.1016\/j.pmedr.2023.102305_b0135","unstructured":"Organization, W.H., 2019. International Statistical Classification of Diseases and Related Health Problems 10th Revisions. https:\/\/icd.who.int\/browse10\/2019\/en."},{"key":"10.1016\/j.pmedr.2023.102305_b0140","first-page":"50","volume":"101","author":"Oviedo-Joekes","year":"2019","journal-title":"Treatment with injectable hydromorphone: comparing retention in double blind and open label treatment periods"},{"key":"10.1016\/j.pmedr.2023.102305_b0145","doi-asserted-by":"crossref","unstructured":"Pearce, L.A., Min, J.E., Piske, M., et al., 2020. Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study. 368.","DOI":"10.1136\/bmj.m772"},{"issue":"1","key":"10.1016\/j.pmedr.2023.102305_b0150","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s12888-022-04175-9","article-title":"Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine\/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province","volume":"22","author":"Sadek","year":"2022","journal-title":"BMC Psychiatr."},{"issue":"1","key":"10.1016\/j.pmedr.2023.102305_b0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-021-10714-y","article-title":"The opioid crisis is driving mortality among under-served people living with HIV in British Columbia, Canada","volume":"21","author":"Salters","year":"2021","journal-title":"BMC Public Health"},{"issue":"9","key":"10.1016\/j.pmedr.2023.102305_b0160","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.pmedr.2023.102305_b0165","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2018.04.026","article-title":"Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006\u20132016","volume":"189","author":"Soc\u00edas","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pmedr.2023.102305_b0170","doi-asserted-by":"crossref","first-page":"102696","DOI":"10.1016\/j.drugpo.2020.102696","article-title":"Trajectories of retention in opioid agonist therapy in a Canadian setting","volume":"77","author":"Soc\u00edas","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.pmedr.2023.102305_b0175","doi-asserted-by":"crossref","unstructured":"Sordo, L., Barrio, G., Bravo, M.J., et al., 2017. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. 357, j1550.","DOI":"10.1136\/bmj.j1550"},{"key":"10.1016\/j.pmedr.2023.102305_b0180","doi-asserted-by":"crossref","first-page":"103195","DOI":"10.1016\/j.drugpo.2021.103195","article-title":"Overdose mortality is reducing the gains in life expectancy of antiretroviral-treated people living with HIV in British Columbia, Canada","volume":"96","author":"St-Jean","year":"2021","journal-title":"Int. J. Drug Policy"},{"issue":"1","key":"10.1016\/j.pmedr.2023.102305_b0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0137-5","article-title":"Opioid use disorder","volume":"6","author":"Strang","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.pmedr.2023.102305_b0190","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s12913-022-07877-8","article-title":"Measuring treatment attrition at various stages of engagement in Opioid Agonist Treatment in Ontario Canada using a cascade of care framework","volume":"22","author":"Tahsin","year":"2022","journal-title":"BMC Health Serv. Res."},{"issue":"22","key":"10.1016\/j.pmedr.2023.102305_b0195","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2013tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.pmedr.2023.102305_b0200","unstructured":"World Health Organization, 2009. International Classification of Diseases 9th Revisions, Clinical Modifications. http:\/\/icd9.chrisendres.com\/index.php."},{"key":"10.1016\/j.pmedr.2023.102305_b0205","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugalcdep.2019.01.038","article-title":"Predictors of timely opioid agonist treatment initiation among veterans with and without HIV","volume":"198","author":"Wyse","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"13","key":"10.1016\/j.pmedr.2023.102305_b0210","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/QAD.0000000000003341","article-title":"A 20-year population-based study of all-cause and cause-specific mortality among people with concurrent HIV and psychotic disorders","volume":"36","author":"Yazdani","year":"2022","journal-title":"AIDS (London, England)."},{"issue":"6","key":"10.1016\/j.pmedr.2023.102305_b0215","doi-asserted-by":"crossref","first-page":"248","DOI":"10.24095\/hpcdp.38.6.05","article-title":"At-a-glance - Impact of drug overdose-related deaths on life expectancy at birth in British Columbia","volume":"38","author":"Ye","year":"2018","journal-title":"Health Promot .Chronic Dis. Prev. Can."}],"container-title":["Preventive Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335523001961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335523001961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T03:50:45Z","timestamp":1732679445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211335523001961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":43,"alternative-id":["S2211335523001961"],"URL":"https:\/\/doi.org\/10.1016\/j.pmedr.2023.102305","relation":{},"ISSN":["2211-3355"],"issn-type":[{"value":"2211-3355","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing opioid agonist therapy uptake and factors associated with treatment retention among people with HIV in British Columbia, Canada","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmedr.2023.102305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102305"}}